We conclusively proved that CAV1 in BC-derived sEVs promote the neutrophil recruitment through the TLR4-NF-κB-IL-6/CCL2 axis and neutrophil N2-type polarization through the TLR4/NF-κB/NLRP3 pathway. The gene discussed is CAV1; the disease is breast cancer.